Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and molecular genetic characterization of myelofibrosis.

Current opinion in hematology - 1 Mar 2015

Hobbs Gabriela S, Rampal Raajit K

Abstract excerpt

PURPOSE OF REVIEW: The myeloproliferative neoplasms include polycythemia vera, essential thrombocythemia, and myelofibrosis. Of these, myelofibrosis often has the most aggressive course. There is, however, often significant clinical heterogeneity among patients with myelofibrosis. We seek to summarize recent clinical and biological findings in myelofibrosis as well as review the spectrum of clinically relevant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ASXL1 gene
Share to JAK2 gene
Share to TET2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Mutation

Share to Primary Myelofibrosis

Share to Prognosis

Source

Identifiers

PMID: 25635755
DOI: 10.1097/MOH.0000000000000122

Genes

ASXL1
JAK2
TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and molecular genetic characterization of myelofibrosis.PMID 25635755Read ↗

Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment AdvancementsSemantic proximity Read ↗

A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management.Semantic proximity Read ↗

World Health Organization Classification, Evaluation, and Genetics of the Myeloproliferative Neoplasm VariantsSemantic proximity Read ↗

Recent advances in understanding myelofibrosis and essential thrombocythemiaSemantic proximity Read ↗

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.Semantic proximity Read ↗

Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms.Semantic proximity Read ↗

[Myelofibrosis: A review].Semantic proximity Read ↗

Myelofibrosis biology and contemporary management.Semantic proximity Read ↗

Myeloproliferative Neoplasms: A Contemporary Review.Semantic proximity Read ↗

Myeloproliferative Neoplasms.Semantic proximity Read ↗

Distinct clinical, molecular, and treatment response profiles in primary and secondary myelofibrosis: a single-center retrospective study.Semantic proximity Read ↗

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation SequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.